6,036 filings
Page 2 of 100
6-K
xtp 7lhsrbh
17 Apr 24
Director/pdmr Shareholding
10:52am
6-K
8nh8pddettb4taknxv
17 Apr 24
Results from Long-term Data Relating to Shingrix
6:12am
6-K
sam39l 8pko9m0
17 Apr 24
GSK Announces Additional EAGLE-1 Results
6:07am
6-K
hjbxj7
16 Apr 24
Amendment - Director/pdmr Shareholding
9:49am
6-K
mq0j2
16 Apr 24
Fda Accepts GSK Meningitis Vaccine Candidate File
6:20am
6-K
xkpfc abff25uc6
15 Apr 24
Director/pdmr Shareholding
11:26am
6-K/A
bo9ey8wrldvu2fn7
4 Apr 24
Replacement - Total Voting Rights
7:46am
6-K
y5zkzd4oer90eb1wn
2 Apr 24
Total Voting Rights
1:17pm
SC 13D/A
h03y311
28 Mar 24
Nkarta / GSK ownership change
5:06pm
6-K
3hv3y2is80 52
26 Mar 24
Director/pdmr Shareholding
7:45am
F-3ASR
zu4o8orc
25 Mar 24
Automatic shelf registration (foreign)
2:01pm
6-K
xt7ijz05u tw0xk5
25 Mar 24
Notice of Agm
9:38am
6-K
2jt0x2rhiil 0eiq25u
22 Mar 24
Transfer of Treasury Shares
12:48pm
6-K
wajh iuzm6gbcu
22 Mar 24
Director/pdmr Shareholding
12:17pm
6-K
eyqid0ql qe4y2
18 Mar 24
New Phase III Jemperli Data In Endometrial Cancer
9:56am
6-K
zqxwngypu owv40
13 Mar 24
Director/pdmr Shareholding
1:15pm
6-K
bbs8wkf8550cz ll5
8 Mar 24
Board Committee Change
12:48pm
6-K
5edcoz2hwvmy5n5
7 Mar 24
GSK Announces Positive Blenrep DREAMM-8 Results
6:13am
6-K
vqowhesb7ikjp
6 Mar 24
VIIV Lai VS Oral Soc Data In Adherence-challenged
11:11am
6-K
nyj7b 61onkq
5 Mar 24
GSK Annual Report 2023 on Form 20 F
1:09pm